Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. - Wikidata - awgldk - TriplyDB

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.

http://www.wikidata.org/entity/Q35212074

about

Ovarian cancer screening--current status, future directions Challenging and complex decisions in the management of the BRCA mutation carrier Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer Ovarian cancer screening: development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials.Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers Early detection biomarkers for ovarian cancer.Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.Can CA-125 predict lymph node metastasis in epithelial ovarian cancers in Turkish population?Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort Biomarkers for early detection of ovarian cancer.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.CA125 reference values change in male and postmenopausal female subjects.Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

P2860

Q27004471-4A4F5335-F8B8-41C5-813F-185058FC6A7A Q27026559-38DF27AB-BC23-48C5-9858-6D897FE89C49 Q30370475-89C43556-4E6C-4600-94EE-4E5304F0F058 Q33850475-850260D8-A696-4D26-A747-BA0894BAC627 Q34447404-4EF84AD6-1B06-4E3C-A518-154AEF2FC4FC Q34451931-348D413D-5906-4FA4-B494-DF6E1C298648 Q34637879-E656CCAC-E3C4-4906-825B-6FCA85ADBDB5 Q35097362-EDFB4C08-3CC1-4006-B580-A5D781505310 Q35396400-17D9FD56-DDCD-412A-9E38-B6E9DE3D89E3 Q36370010-96C566EF-85F4-42FA-BB18-FC6D9E385C67 Q36372283-694A6713-562D-4C0B-8499-704BA60E6B2B Q36520143-DF90060E-7B15-4919-8D79-95E6E9A5ED25 Q37516304-4ABECFB3-F5F3-4366-8F9A-1A35B77A76F2 Q37699931-09D631DA-E960-4218-B40C-CE9329B291AE Q37713640-0459F34B-EB65-4178-87EE-78CA7E52ECA4 Q38087982-ED05B8B7-175E-4B92-8F8F-975DA630BBD5 Q38649539-3729A4A0-9E4F-4365-BF52-E7C834BD45A5 Q38988184-591C4573-9E08-49F1-9592-0E95CD4A46CB Q45759458-94F5D85D-770B-4E14-ADFA-3DF04713B3C9 Q47958061-F7B504A0-E806-4907-A064-F2AFACDDE1B7

P2860

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.

http://www.wikidata.org/entity/Q35212074

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Large prospective study of ova ...... defined by menopausal status.

@ast

Large prospective study of ova ...... defined by menopausal status.

@en

type

label

Large prospective study of ova ...... defined by menopausal status.

@ast

Large prospective study of ova ...... defined by menopausal status.

@en

prefLabel

Large prospective study of ova ...... defined by menopausal status.

@ast

Large prospective study of ova ...... defined by menopausal status.

@en

P1433

Q35212074-21BD3D3E-2B9E-475C-B32E-D7449659740E

P1476

Q35212074-DA56BE41-3A18-4F0E-ABAA-84280ABF8F16

P2093

Q35212074-021F6586-3A33-4FA0-A7F8-BBFC6DA4F78C

Q35212074-065387F1-5F34-4B3B-B140-CEF5D7697F17

Q35212074-0C66D1D2-67B4-492D-A6B8-02DE3F241B58

Q35212074-214F86A9-C5B9-42AB-AD3C-BDCE07CB5D48

Q35212074-349EA0D6-6CDE-4CD7-A29C-3A3E71D46B63

Q35212074-42D0B05A-983E-464D-802F-B6AD6FA2B9E3

Q35212074-474FA9F7-3ACB-4231-B53A-1DBC9F0C9DCC

Q35212074-5383D231-36E3-402D-8D38-DAC2B3DA329B

Q35212074-585673BD-BC5F-4BB0-B29F-4F147035C1C5

Q35212074-5F0BB9F3-66EB-4D16-AB35-7443DD7F5CA0

P2860

Q35212074-362DD236-CA71-4D40-814F-81374FF805F5

Q35212074-8E955B09-D587-46B3-9F36-A4E5531B4763

Q35212074-AE8143E1-BC23-473B-A85B-D12AB1CC5CB1

Q35212074-CDDA7797-98D2-41B5-8917-9EA46567808B

Q35212074-D008705A-FA54-4B59-8F13-332B31D09F6E

Q35212074-E2DC0553-B28F-4F58-8809-67806F117F66

Q35212074-F32E8386-450F-4F03-95CE-F5C1D478883C

Q35212074-FFB31A9D-8C69-42E6-B172-C9B9474176C9

P304

Q35212074-B6324A34-61D2-44A5-AA3E-18F64B0A130C

P31

Q35212074-3A3E1C75-BA96-4730-B11B-913A33D909EE

P356

Q35212074-8BA34BDD-B3E8-4C9B-BE60-5A63B7EFA5BA

P433

Q35212074-EED099AC-1B25-4204-8073-1415D48F2E68

P478

Q35212074-4F072182-41A0-4FF0-84D0-94F4E1EDCFF9

P50

Q35212074-0B6F41E9-90CC-4B37-A617-FBE7BE70EAF5

Q35212074-837C4EA9-9262-4626-B36C-DDA4E1E5E8F6

Q35212074-C37554F4-3411-4930-8FBA-BA7BB94D6BA0

Q35212074-C59385BD-765F-4AF2-A8DD-C6E06331E32B

P577

Q35212074-2D0F47ED-908D-48F2-B828-36B2CF9BCEB8

P698

Q35212074-8BD0B6A1-13D6-474E-87C3-276FAAD30586

P921

Q35212074-491D82D8-502E-49C7-A782-1CC1AABEB6F9

P932

Q35212074-DBE166E0-8402-4BA6-B91F-5B742B09A95A

P356

1940-6207.CAPR-10-0402

P1433

Cancer Prevention Research

P1476

Large prospective study of ova ...... defined by menopausal status.

@en

P2093

Andrew Berchuck

http://www.w3.org/2001/XMLSchema#string

Carol H Kasten

http://www.w3.org/2001/XMLSchema#string

Carol J Fabian

http://www.w3.org/2001/XMLSchema#string

Charles W Drescher

http://www.w3.org/2001/XMLSchema#string

Deborah K Armstrong

http://www.w3.org/2001/XMLSchema#string

Dianne M Finkelstein

http://www.w3.org/2001/XMLSchema#string

Gustavo C Rodriguez

http://www.w3.org/2001/XMLSchema#string

Ira R Horowitz

http://www.w3.org/2001/XMLSchema#string

John O Schorge

http://www.w3.org/2001/XMLSchema#string

Karen Lu

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

The CA 125 tumour-associated antigen: a review of the literature.

Factors influencing serum CA125II levels in healthy postmenopausal women.

Screening for ovarian cancer: a pilot randomised controlled trial.

Prospectively detected cancer in familial breast/ovarian cancer screening.

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

P304

1401-1408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-10-0402

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Susan M Domchek

Claudine Isaacs

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21893500

http://www.w3.org/2001/XMLSchema#string

P921

P932

3172691

http://www.w3.org/2001/XMLSchema#string